|
|
Volumn 8, Issue 6, 2009, Pages 437-438
|
|
Novel anticancer strategy targets DNA repair
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 (2 METHYL 2 PYRROLIDINYL) 1H BENZIMIDAZOLE 4 CARBOXAMIDE;
AG 014699;
ANTINEOPLASTIC AGENT;
BRCA1 PROTEIN;
BRCA2 PROTEIN;
BSI 201;
CARBOPLATIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
GEMCITABINE;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;
OLAPARIB;
UNCLASSIFIED DRUG;
APOPTOSIS;
ARTICLE;
BREAST CANCER;
CLINICAL TRIAL;
COLORECTAL CANCER;
DNA DAMAGE;
DNA REPAIR;
DRUG EFFICACY;
DRUG TOLERABILITY;
GENE MUTATION;
GLIOBLASTOMA;
HUMAN;
MELANOMA;
MONOTHERAPY;
OVARY CANCER;
PANCREAS CANCER;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
UTERUS CANCER;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE II AS TOPIC;
DNA REPAIR;
DRUGS, INVESTIGATIONAL;
GENE TARGETING;
HUMANS;
POLY(ADP-RIBOSE) POLYMERASES;
|
|
EID: 66749178920
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2916 Document Type: Article |
|
Times cited : (16)
|
|
References (0)
|